Efficacy of Eplerenone in the Management of Mineralocorticoid Excess in Men With Metastatic Castration-resistant Prostate Cancer Treated With Abiraterone Without Prednisone

MLA

Neeraj Agarwal, et al. “Efficacy of Eplerenone in the Management of Mineralocorticoid Excess in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Without Prednisone.” Clinical Genitourinary Cancer, vol. 15, no. 4, Oct. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0aff4d9f93d6fbfc351cb5b9ddaded5f&authtype=sso&custid=ns315887.

APA

Neeraj Agarwal, Julia A. Batten, David D. Stenehjem, Kenneth M. Boucher, Anitha Alex, Sumati Gupta, David C. Gaston, Andrew W. Hahn, Erin B. Bailey, & David Gill. (2016). Efficacy of Eplerenone in the Management of Mineralocorticoid Excess in Men With Metastatic Castration-resistant Prostate Cancer Treated With Abiraterone Without Prednisone. Clinical Genitourinary Cancer, 15(4).

Chicago

Neeraj Agarwal, Julia A. Batten, David D. Stenehjem, Kenneth M. Boucher, Anitha Alex, Sumati Gupta, David C. Gaston, Andrew W. Hahn, Erin B. Bailey, and David Gill. 2016. “Efficacy of Eplerenone in the Management of Mineralocorticoid Excess in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Without Prednisone.” Clinical Genitourinary Cancer 15 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0aff4d9f93d6fbfc351cb5b9ddaded5f&authtype=sso&custid=ns315887.